Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery DiseaseTakuo Emoto, Ken‐ichi Hirata, Tomoya Yamashita et al.|Journal of Atherosclerosis and Thrombosis|2016Cited by 314
Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery diseaseTakuo Emoto, Ken‐ichi Hirata, Taiji Mizoguchi et al.|Heart and Vessels|2016Cited by 174
Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitorAnna So, Wataru Ogawa, Kazuhiko Sakaguchi et al.|Endocrine Journal|2020Cited by 50
Insulin Secretion and Insulin Sensitivity Before and After Surgical Treatment of Pheochromocytoma or ParagangliomaHisako Komada, Wataru Ogawa, Yushi Hirota et al.|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 47
Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open‐label study (SOAR‐KOBE Study)Hiroshi Miura, Wataru Ogawa, Kazuhiko Sakaguchi et al.|Journal of Diabetes Investigation|2019Cited by 34